Aquigen Bio Sciences

  In the realm of pharmaceutical R&D, where precision and compliance are non-negotiable, the quality of reference standards plays a pivotal role. Among the most specialized of these are cholesterol impurity standards — used extensively in method development, validation, and regulatory filing for formulations and active pharmaceutical ingredients. One such high-value standard is   24-Dehydrolathosterol , a compound that offers critical analytical support in sterol-related drug profiling. What is 24-Dehydrolathosterol? 24-Dehydrolathosterol (CAS Number: 17608–47–8)  is a sterol intermediate in cholesterol biosynthesis. It features a distinct molecular structure, with the formula  C₂₇H₄₄O  and a molecular weight of  384.64 g/mol . Its unique configuration makes it particularly relevant for research and analytical applications that require accurate quantification and separation of cholesterol-related impurities. At Aquigen Bio, this compound is available un...

In recent years, stringent scrutiny regarding the quality of pharmaceutical products has exposed the critical need for  advanced analytical methods  to identify and quantify impurities. Among these impurities, N-Nitroso compounds (NOCs) have gained significant attention, owing to their potential carcinogenicity even at trace levels. Regulatory agencies, including the US FDA and EMA, consistently refine their guidelines to ensure safer drug formulations for consumers. Hence, detecting N-nitroso impurities in active pharmaceutical ingredients (APIs), excipients, and drug products has become a high-priority challenge for manufacturers. Characterized by the presence of the nitroso functional group (-N=O), N-nitroso impurities can be inadvertently formed during manufacturing processes, commonly through reactions between nitrites and secondary or tertiary amines. Their detection and quantitation require sophisticated instrumentation, precise methodologies, and an in-depth understand...

In recent years, empagliflozin has emerged as a significant medication in the management of type 2 diabetes mellitus. This sodium-glucose cotransporter 2 (SGLT2) inhibitor offers a novel approach to diabetes treatment by targeting renal glucose reabsorption, leading to improved glycemic control and potentially offering additional health benefits. In this article, we delve into what empagliflozin is used for, its benefits, and important considerations for its use. What is Empagliflozin? Empagliflozin is a medication belonging to the class of SGLT2 inhibitors. These drugs work by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose from the urine back into the bloodstream. By blocking this protein, empagliflozin promotes the excretion of excess glucose through the urine, thereby lowering blood sugar levels in individuals with type 2 diabetes. Uses of Empagliflozin: Type 2 Diabetes Management : The primary use of empagliflozin is in the management of t...